Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2022-04-26 00:00:00 ET · period of report 2022-04-25 · accession 0001450324-22-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-26 | 2022-04-25 | AIM | Rodino Peter W III | COO, Sec, Gen. Counsel | A - Grant | $1.02 | +4,902 | 63.2K | +8% | +$5,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-25 | A | A | 4,902 | $1.02 | 63,193 | D | — | — |